Literature DB >> 9745067

Thoracoscopic transdiaphragmatic microwave coagulation therapy for a liver tumor.

Y Yamashita1, T Sakai, T Maekawa, K Watanabe, A Iwasaki, T Shirakusa.   

Abstract

BACKGROUND: Microwave coagulation therapy (MCT) for hepatocellular carcinoma, which induces tumor coagulonecrosis, is now recognized as an efficient treatment. However, when a tumor is located just below the top of the diaphragmatic dome, laparotomical MCT requires a large incision, and percutaneous MCT is sometimes impossible. PATIENTS AND METHODS: The patients were four men and two women. There were four cases of hepatocellular carcinoma and two cases of liver metastasis from colorectal cancer. All tumors were located below the top of the diaphragmatic dome. Thoracoscopic transdiaphragmatic MCT (TTMCT) was performed under general anesthesia using an endotracheal double-lumen tube. Identification of the tumor site in the liver was performed using an ultrasonic probe under thoracoscopic observation. After the diaphragm above the tumor was opened, a needle electrode to transmit microwaves was inserted directly into the tumor. Microwave irradiation was repeated to coagulate the entire lesion. After completion of TTMCT, the diaphragm was closed thoracoscopically.
RESULTS: TTMCT was successfully administered to cancerous lesions in all six patients. The postoperative course was uneventful, and the average postoperative hospitalization period was 10.5 days. None of the patients has shown any recurrence during a follow-up period of 4-23 months.
CONCLUSIONS: TTMCT was performed without any difficulty using the thoracoscopic surgical technique, and its therapeutic outcome was satisfactory. This is effective for tumors located just below the top of the diaphragmatic dome.

Entities:  

Mesh:

Year:  1998        PMID: 9745067     DOI: 10.1007/s004649900831

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  4 in total

1.  Ultrasonic aspiration hepatectomy for 136 patients with hepatocellular carcinoma.

Authors:  Wei Wu; Xin-Bao Lin; Jian-Min Qian; Zhen-Ling Ji; Zao Jiang
Journal:  World J Gastroenterol       Date:  2002-08       Impact factor: 5.742

2.  Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis.

Authors:  S A Curley; F Izzo; L M Ellis; J Nicolas Vauthey; P Vallone
Journal:  Ann Surg       Date:  2000-09       Impact factor: 12.969

3.  Transthoracic radiofrequency ablation for hepatic tumor located beneath the diaphragm under one-lung ventilation: A case report.

Authors:  Sung Wook Park; Youngsoon Kim; Hee Yong Kang; Ann Hee You; Jong Mi Jeon; Hyunho Woo; Jeong-Hyun Choi
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.889

4.  Thoracoscopic Ablation of Critically Located Liver Tumors: A Safety and Efficacy Cohort Study.

Authors:  Umberto Cillo; Michele Finotti; Chiara Di Renzo; Alessandro Vitale; Giacomo Zanus; Enrico Gringeri; Alessandra Bertacco; Marina Polacco; Francesco D'Amico
Journal:  Front Surg       Date:  2021-03-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.